LIVERGREEN Trial
Cross-source consensus on LIVERGREEN Trial from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Risks & contraindications
Where it comes from
Other
Highlighted claims
- The LIVERGREEN trial tests whether preoperative ICG improves malignant liver tumour detection during minimally invasive surgery compared with standard imaging and intraoperative ultrasound. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- The trial is prospective, non-randomised, multicentre, phase IV, and classified as low intervention. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- The study is being conducted at four academic tertiary hepatobiliary surgery centres in Catalonia, Spain. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- The planned sample size for LIVERGREEN is 173 patients. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial
- The trial's main limitations are its non-randomised design and reliance on visual fluorescence interpretation at the beginning of the study. — Indocyanine green fluorescence for intraoperative detection of liver tumours in minimally invasive surgery: protocol for the LIVERGREEN phase IV multicentre clinical trial